Clinical, angiographic, and procedural data of patients with AMI, patients with SA, and healthy CTRLs
. | AMI, n = 26 . | SA, n = 10 . | CTRLs, n = 17 . |
|---|---|---|---|
| Age, y, mean (range) | 60 (41-74) | 60 (46-75) | 51 (40-70) |
| Males (%) | 21 (80) | 8 (80) | 14 (80) |
| Body mass index | 26.7 | 29.7 | 25.4 |
| Cardiovascular risk factors (%) | |||
| Family history | 6 (25) | 4 (40) | 3 (18) |
| Hypertension | 8 (30) | 4 (40) | 4 (23) |
| Dislipidemia | 5 (20) | 5 (50) | 3 (18) |
| Smoking | 18 (70)* | 2 (20) | 2 (12) |
| Diabetes | 2 (7) | 3 (30) | 1 (6) |
| Previous angina pectoris (%) | 2 (8) | 0 (0) | 0 (0) |
| Statins (%) | 10 (38) | 5 (50) | 2 (12) |
| ACE inhibitor (%) | 14 (53) | 4 (40) | 4 (23) |
| Anterior AMI (%) | 12 (45) | — | — |
| Multivessel CAD (%) | 8 (31)† | 7 (70) | — |
| Before PTCA (%) | |||
| TIMI 0-2 | 23 (88) | — | — |
| TIMI 3 | 3 (12) | — | — |
| Collateral flow | 1 (4) | — | — |
| Time to balloon, min (range) | 195 (180-300) | — | — |
| After PTCA (%) | |||
| TIMI 0-2 | 2 (8) | — | — |
| TIMI 3 | 24 (92) | — | — |
| pCK, mU/mL (range) | 2055 (161-3907) | — | — |
| pCK-MB, mU/mL (range) | 221 (77-372) | — | — |
| LVEF (%) | |||
| 24 h | 47 ± 9 | — | — |
| 1 y | 53 ± 8 | — | — |
| LVWMSI (%) | |||
| 24 h | 1.8 ± 0.31 | — | — |
| 1 y | 1.5 ± 0.3 | — | — |
. | AMI, n = 26 . | SA, n = 10 . | CTRLs, n = 17 . |
|---|---|---|---|
| Age, y, mean (range) | 60 (41-74) | 60 (46-75) | 51 (40-70) |
| Males (%) | 21 (80) | 8 (80) | 14 (80) |
| Body mass index | 26.7 | 29.7 | 25.4 |
| Cardiovascular risk factors (%) | |||
| Family history | 6 (25) | 4 (40) | 3 (18) |
| Hypertension | 8 (30) | 4 (40) | 4 (23) |
| Dislipidemia | 5 (20) | 5 (50) | 3 (18) |
| Smoking | 18 (70)* | 2 (20) | 2 (12) |
| Diabetes | 2 (7) | 3 (30) | 1 (6) |
| Previous angina pectoris (%) | 2 (8) | 0 (0) | 0 (0) |
| Statins (%) | 10 (38) | 5 (50) | 2 (12) |
| ACE inhibitor (%) | 14 (53) | 4 (40) | 4 (23) |
| Anterior AMI (%) | 12 (45) | — | — |
| Multivessel CAD (%) | 8 (31)† | 7 (70) | — |
| Before PTCA (%) | |||
| TIMI 0-2 | 23 (88) | — | — |
| TIMI 3 | 3 (12) | — | — |
| Collateral flow | 1 (4) | — | — |
| Time to balloon, min (range) | 195 (180-300) | — | — |
| After PTCA (%) | |||
| TIMI 0-2 | 2 (8) | — | — |
| TIMI 3 | 24 (92) | — | — |
| pCK, mU/mL (range) | 2055 (161-3907) | — | — |
| pCK-MB, mU/mL (range) | 221 (77-372) | — | — |
| LVEF (%) | |||
| 24 h | 47 ± 9 | — | — |
| 1 y | 53 ± 8 | — | — |
| LVWMSI (%) | |||
| 24 h | 1.8 ± 0.31 | — | — |
| 1 y | 1.5 ± 0.3 | — | — |
— indicates not applicable; ACE, angiotensin-converting enzyme; CAD, coronary artery disease; PTCA, primary percutaneous transluminal coronary angioplasty; TIMI, thrombolysis in myocardial infarction; LVEF, left ventricular ejection fraction; and LVWMSI, left ventricular wall motion score index.
P ≤ .008 versus SA and CTRLs.
P = .03 versus SA.